Аннотация:
Thiamphenicol glycinate acetylcysteinate (TGA) is a combination of thiamphenicol, a broad-spectrum antibiotic, and mucolytic drug N-acetylcysteine. This article is a review of pharmacological, microbiological, and clinical effects of this combined drug. Inhaled TGA could be considered as a worthy alternative for oral mucolytics and oral antibiotics in treatment of upper and lower airway diseases, such as acute and chronic rhinosinusitis, otitis media, tonsillitis, acute bronchitis, and acute exacerbation of chronic bronchitis and chronic obstructive pulmonary disease, in children and adults. © 2018 National Research University Higher School of Economics. All rights reserved.
Ключевые слова:
Acute bronchitis; Chronic bronchitis; Chronic obstructive pulmonary disease; Exacerbation; N-acetylcysteine; Thiamphenicol; Thiamphenicol glycinate acetylcysteinate; Upper and lower airway diseases
mucolytic agent; thiamphenicol; thiamphenicol glycinate acetylcysteinate; unclassified drug; antibiotic therapy; bronchitis; chronic bronchitis; chronic obstructive lung disease; chronic rhinosinusitis; disease exacerbation; human; otitis media; pulmonology; Review; tonsillitis
Капустина В. А. Валентина Андреевна 1981-
Овчаренко С. И. Светлана Ивановна 1937-
Kapustina V. A. Valentina Andreevna 1981-
Ovcharenko S. I. Svetlana Ivanovna 1937-
Antibacterial inhalation therapy with thiamphenicol glycinate acetylcysteinate in pulmonology
Текст визуальный непосредственный
Пульмонология
Научно-практический журнал "Пульмонология"
Т. 28, Вып. 4 С. 483-489
2018
Обзор
Acute bronchitis Chronic bronchitis Chronic obstructive pulmonary disease Exacerbation N-acetylcysteine Thiamphenicol Thiamphenicol glycinate acetylcysteinate Upper and lower airway diseases
mucolytic agent thiamphenicol thiamphenicol glycinate acetylcysteinate unclassified drug antibiotic therapy bronchitis chronic bronchitis chronic obstructive lung disease chronic rhinosinusitis disease exacerbation human otitis media pulmonology Review tonsillitis
Thiamphenicol glycinate acetylcysteinate (TGA) is a combination of thiamphenicol, a broad-spectrum antibiotic, and mucolytic drug N-acetylcysteine. This article is a review of pharmacological, microbiological, and clinical effects of this combined drug. Inhaled TGA could be considered as a worthy alternative for oral mucolytics and oral antibiotics in treatment of upper and lower airway diseases, such as acute and chronic rhinosinusitis, otitis media, tonsillitis, acute bronchitis, and acute exacerbation of chronic bronchitis and chronic obstructive pulmonary disease, in children and adults. © 2018 National Research University Higher School of Economics. All rights reserved.